AARD vs CMG · $284.4M cap vs P/E 50, rev $3.35B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus Chipotle Mexican Grill Inc (CMG) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
Chipotle Mexican Grill Inc (CMG) is a restaurants company listed on US.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
Latest reported CMG revenue for 2026-06-30 was $3.35B. Net income was $403.5M. Revenue was up 8.4% from 2026-03-31 to 2026-06-30. CMG currently screens at market cap $76.00B and trailing P/E 50.0.
AARD currently screens at market cap $284.4M. CMG currently screens at market cap $76.00B and trailing P/E 50.0.
Not investment advice. Open the AARD and CMG stock pages for the full models.
Not investment advice.